NDC 10019-982 – Cyclophosphamide
Cyclophosphamide 25 mg/1 · Tablet · Oral
Product NDC10019-982
Product details
- Brand name
- Cyclophosphamide
- Generic name
- Cyclophosphamide
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA012141
- Marketed since
- August 7, 2020
- Listing expires
- December 31, 2027
Active ingredients
- Cyclophosphamide 25 mg/1
Uses, dosage, side effects and warnings for Cyclophosphamide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 10019-982-01 | 1 BOTTLE in 1 CARTON (10019-982-01) / 100 TABLET in 1 BOTTLE (10019-982-09) | Aug 7, 2020 |
Other Cyclophosphamide products
- 10019-984 Cyclophosphamide 50 mg/1 · Tablet · Baxter Healthcare Corporation
- 62332-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 70121-1238 Cyclophosphamide 500 mg/25mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1239 Cyclophosphamide 1 g/50mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1240 Cyclophosphamide 2 g/100mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 83634-207 Cyclophosphamide 2 g/100mL · Injection, Powder, For Solution · Avenacy, LLC
- 83634-205 Cyclophosphamide 500 mg/25mL · Injection, Powder, For Solution · Avenacy, LLC
- 83634-206 Cyclophosphamide 1 g/50mL · Injection, Powder, For Solution · Avenacy, LLC
- 83831-116 Cyclophosphamide 500 mg/mL · Injection · Avyxa Pharma, LLC